OOQB yields 13.80% · JNJ yields 2.13%● Live data
📍 OOQB pulled ahead of the other in Year 1
Combined, OOQB + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of OOQB + JNJ for your $10,000?
OOQB provides exposure to the NASDAQ-100 and Bitcoin. The fund aims for long-term capital appreciation by using US-listed futures, pooled investment vehicles, and collateral. The fund targets 100% notional exposure for the returns of each asset class or an aggregate of 200%. The strategy seeks to magnify exposure so that every $1 investment is $1 exposure each to the Nasdaq-100 and Bitcoin. The fund does not invest directly in Bitcoin but uses Bitcoin price reflected in the next or second-to-next expiring futures contract. In the case of other Bitcoin-linked investments, value is calculated by the average. Through a wholly owned Cayman Islands subsidiary, the fund can invest in futures, ETPs with similar exposure, equities, and cash and cash equivalents. The actively managed ETF has full discretion to adjust the portfolio at any given time, while maintaining its tax status. Therefore, tracking deviation may be greater than the performance of the Nasdaq-100 or Bitcoin.
Full OOQB Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.